CBCN Advocacy Gu ides: Tak ing Act ion on Canad

CADTH has stated that they are looking to improve and align their procedures, submission requirements, and internal processes by adapting the best practices of each of the individual drug review processes (based on principals of transparency, efficiency, timeliness, sustainability, and equity). [...] What Is The Impact On Pat ients? The cancer patient community has raised concerns about many of the changes to the review process. [...] The changes to the review process could undermine CADTH?s stated commitment to the principals of transparency, equity and timeliness by operating non-transparently, and limiting the ability of experienced clinicians and patients from advising the process. [...] Write to the President and CEO of CADTH - Contact the head of CADTH to voice your concerns about the proposed new changes to CADTH?s drug review process. [...] Write to the Minister of Health - Share your thoughts on the proposed changes and the impacts they could have on cancer patients with the Minister of Health.